BCBBS® Program Information
BCBBS is the first and only accredited Board Certification for the Biologics and Biosimilars specialty area
4.6
|
1k + Graduates
More About BCBBS®
What is BCBBS®?
The Board Certified Biologics and Biosimilars Specialist Program (BCBBS) is a self-paced, online, board certification program that strives to set the standard of excellence in the field of biologics and biosimilars. The BCBBS program has made it its mission to establish expertise among professionals involved in the optimization of biological therapy. The BCBBS enhances your understanding of the regulatory and analytical landscape of biologics and biosimilars allowing you to power your career in a rapidly expanding field.
This comprehensive, 9-module, self-paced, e-learning, online program trains you on the most critical knowledge areas within the biologics & biosimilars space to help make you a subject matter expert in the field. With BCBBS certification, you've proven your commitment to raising the bar in patient care through intensive study, self-assessment, and evaluation.
BCBBS® Background
The first biosimilar entered the US marketplace in 2015 and since then approximately 40 biosimilars have been approved. The healthcare system has been waiting for advancements in biologics medicines to improve patient quality of life. Often, drug pricing costs had been an obstacle for many patients and providers in accessing biologics. With more biosimilars expected to receive approval across several therapeutic areas over the next 5-10 years, the importance of educating the life sciences and healthcare communities on biologics and biosimilars has never been more important.
Along with the Food and Drug Administration (FDA) which as developed a curriculum toolkit, The Accreditation Council for Medical Affairs (ACMA) has developed the first and only recognized US and International Board Certification Program for industry, clinical and scientific professionals in order to create an internationally-accepted standard of knowledge, education, and experience by which leaders in the field will be recognized as Board Certified Biologics and Biosimilars Specialists (BCBBS®)
Learn more about the BCBBS® eligibility criteriaACMA developed the BCBBS® Certification program to evaluate the knowledge, understanding, and application of best practices for the field to help professionals who are either treating patients or those working in the pharmaceutical, biotechnology, medical devices or diagnostic industries to gain a deeper understanding of the biologics & biosimilars field.
What are the advantages of Becoming a Board Certified Biologics & Biosimilars Specialist (BCBBS)?
Becoming a BCBBS visibly speaks to your authority and expertise in this rapidly evolving arena
Be part of a cadre of elite , highly specialized subject matter experts with broadly deployable skills across the healthcare sector
Gain a deep understanding of the manufacturing process, therapeutic application, and evolution of the biologic and biosimilar landscape
Be able to proactively address misconceptions around biosimilars and their interchangeability
Power your knowledge of regulatory and compliance requirements (e.g., FDA, IFPMA, EMA, CFDA) and differentiate the approval pathways between biological products (BLA) and small molecule pathways (NDA)
BCBBS® By the Numbers
9
the number of core competencies included in the program
06
the number of months afforded to complete the program
20
the average number of hours it takes to complete the program
80+
the number of countries where our graduates reside
100
the number of practice questions included to help you pass the board exam
05
the number of attempts allowed for each post-quiz
04
the number of attempts allowed on the board exam
01
the number of clicks required to elevate your career
Why Become a Board Certified Biologics & Biosimilars Specialist (BCBBS)®?
Solidify your reputation as a leading expert in biologics and biosimilars
Get in on the opportunity to power your career in a rapidly growing field
Grow your career and increase your earning potential
Set a standard of excellence among your peers
BCBBS® Outline
9 core competencies
9 pre & post quizzes
Case studies
1 practice exam
1 final exam
Professional certification
BCBBS® Program Structure
Each of the 9 BCBBS core competencies includes:
Pre-Quiz (Optional)
Establishes your existing knowledge of the specific module's content
Module Content
Consists of multiple sections that vary from module to module
Post-Quiz
Determines how well you've absorbed and retained the module content
Time needed to complete
The BCBBS is a self-paced program, and you have six months of access to complete the board certification. On average, most learners complete the program within 2-3 months (approximately 40 hours). You will be given 6 months to complete the program.
Program Learning Outcomes
History of Biological Medicine: Gain a deeper understanding of the evolution of the regulatory landscape of biologics and biosimilars including the drug development process and the importance of these therapies in specific specialties.
Biologics in the U.S. Today: Discover the current landscape of biosimilars and interchangeability and the integration of these therapies into medical guidelines in the United States.
Economic Implications: Review biosimilar reimbursement methodologies to thoughtfully choose therapies for patients and provide affordable therapies.
Regulatory Pathways: Power your knowledge of regulatory requirements (e.g., FDA) and differentiate the approval pathways between biological products (BLA) and small molecule pathways (NDA).